The Journal of Korean Society for Radiation Therapy (대한방사선치료학회지)

Korean Society for Radiation Therapy (대한방사선치료학회)
권호 표지

Absorbed Dose and Effective Dose for Lung Cancer Image Guided Radiation Therapy(IGRT) using CBCT and 4D-CBCT

폐암 영상유도방사선 치료 시 CBCT와 4D-CBCT를 이용한 흡수선량 및 유효선량에 관한 선량 평가

  • Kim, Dae yong (Department of Radiation Oncology, GangNeung Asan Hospital) ;
  • Lee, Woo Suk (Department of Radiation Oncology, GangNeung Asan Hospital) ;
  • Koo, Ki Lae (Department of Radiation Oncology, GangNeung Asan Hospital) ;
  • Kim, Joo Seob (Department of Radiation Oncology, GangNeung Asan Hospital) ;
  • Lee, Sang Hyeon (Department of Radiation Oncology, GangNeung Asan Hospital)
  • 김대용 (울산의대 강릉아산병원 방사선종양학과) ;
  • 이우석 (울산의대 강릉아산병원 방사선종양학과) ;
  • 구기래 (울산의대 강릉아산병원 방사선종양학과) ;
  • 김주섭 (울산의대 강릉아산병원 방사선종양학과) ;
  • 이상현 (울산의대 강릉아산병원 방사선종양학과)
  • Received : 2016.05.27
  • Accepted : 2016.06.23
  • Published : 2016.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : To evaluate the results of absorbed and effective doses using CBCT and 4D-CBCT settings for lung cancer. Materials and Methods : This experimental study. Measurements were performed using a Anderson rando phantom with OSLD(optically stimulated luminescent dosimeters). It was performed computed tomography(Lightspeed GE, USA) in order to express the major organs of the human body. Measurements were obtained a mean value is repeated three times each. Evaluations of effective dose and absorbed dose were performed the CL-IX-Thorax mode and Truebeam-Thorax mode CBCT. Additionally, compared Truebeam-Thorax mode CBCT with Truebeam-Thorax mode 4D-CBCT(Four-dimensional Cone Beam Computed Tomography) Results : Average absorbed dose in the CBCT of CL-IX was measured in lung 2.505cGy, heart 2.595cGy, liver 2.145cGy, stomach 1.934cGy, skin 2.233cGy, in case of Truebeam, It was measured lung 1.725cGy, heart 2.034cGy, liver 1.616cGy, stomach 1.470cGy, skin 1.445cGy. In case of 4D-CBCT, It was measured lung 3.849cGy, heart 4.578cGy, liver 3.497cGy, stomach 3.179cGy, skin 3.319cGy Average effective dose, considered tissue weighting and radiation weighting, in the CBCT of CL-IX was measured lung 2.164mSv, heart 2.241mSVv, liver 0.136mSv, stomach 1.668mSv, skin 0.009mSv, in case of Turebeam, it was measured lung 1.725mSv, heart 1.757mSv, liver 0.102mSv, stomach 1.270mSv, skin 0.005mSv, In case of 4D-CBCT, It was measured lung 3.326mSv, heart 3.952mSv, liver 0.223mSv, stomach 2.747mSv, skin 0.013mSv Conclusion : As a result, absorbed dose and effective Dose in the CL-IX than Truebeam was higher about 1.3 times and in the 4D-CBCT Truebeam than CBCT of Truebeam was higher about 2.2times However, a large movement of the patient and respiratory gated radiotherapy may be more accurate treatment in 4D-CBCT. Therefore, it will be appropriate to selectively used.

목 적 : 폐암 환자의 CBCT와 4D-CBCT를 이용한 영상촬영 시 인접 장기에 미치는 방사선량을 비교 평가해 보고자 한다. 대상 및 방법 : 본 실험을 진행하기 위해 인체모형팬텀(Anderson Rando Phantom, USA)을 이용하였고, 선량측정 위치는 주요 장기가 위치하는 단면에 광유도발광선량계(Opitcally Stimulated Luminescent Dosimeter, OSLD) 1~6개를 부착하였다. 인체내부의 주요 장기를 표현하기 위해 전산화단층촬영(Lightspeed GE, USA)을 하였다. 선형가속기(CL-IX)와 선형가속기(Truebeam 2.5) thorax 모드에서 인체모형팬텀 폐 하부 기준으로 CBCT 방사선량을 측정하였고, 추가적으로 선형가속기(Truebeam 2.5) thorax 모드에서 4D-CBCT 방사선량을 측정하여 기존 CBCT와 비교 하였다. 각각 3회 반복 측정하여 평균값을 얻었다. 결 과 : CBCT로 촬영한 평균 흡수선량 측정치는 CL-IX의 경우 폐 2.505 cGy, 심장 2.595 cGy, 간 2.156 cGy, 위 1.934 cGy, 피부에 2.233 cGy 이었으며, Truebeam의 경우 폐 1.725 cGy, 심장 2.034 cGy, 간 1.616 cGy, 위 1.470 cGy, 피부에 1.445 cGy 이었다. 4D-CBCT 촬영 시 폐 3.849 cGy, 심장 4.578 cGy, 간 3.497 cGy, 위 3.179 cGy, 피부에3.319 cGy 이었다. 조직 가중치와 방사선 가중치를 고려한 평균 유효선량 값은 CBCT의 경우 CL-IX에서 폐 2.164 mSv, 심장 2.241 mSv, 간 0.136 mSv, 위 1.668 mSv, 피부 0.009 mSv 이었고 Truebeam의 경우 폐 1.725 mSv, 심장 1.757 mSv, 간 0.102 mSv, 위 1.270 mSv, 피부에 0.005 mSv 이었다. 4D-CBCT에서는 폐 3.326 mSv, 심장 3.952 mSv, 간 0.223 mSv, 위 2.747 mSv, 피부에 0.013 mSv 이었다. 결 론 : 폐암 환자의 CBCT 촬영 시 Truebeam보다 CL-IX 장비에서 받는 선량이 1.3배 정도 더 높게 나왔으며, Truebeam 장비에서 CBCT 보다 4D-CBCT에서 환자가 받는 선량이 2.2배 정도 높게 나왔다. 하지만 4D-CBCT는 환자의 움직임이 큰 경우나 호흡동조 영상유도방사선치료 시 좀 더 정확한 방사선 치료를 할 수 있어 선택적으로 사용하는 것이 타당 할 것이다.

Keywords

References

  1. L. Wang, S. Hayes, K. Paskalev, et al. Dosimetric comparison of stereotactic body radiotherapy using 4DCT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage
  2. TrueBeam Techinical Reference Guide-Volume2: imaging. VARIAN medical system.
  3. Jeng SC, Tsai CL, Chan WT, et al. Mathematical estimation and in vivo dose measurement for conebeam computed tomography on prostate cancer patients. Radiother Oncol 2009;92:57-61. https://doi.org/10.1016/j.radonc.2009.03.010
  4. Perks JR, Lehmann J, Chen AM, et al. Comparison of peripheral dose from image-guided radiation therapy (IGRT) using kV cone beam CT to intensitymodulated radiation therapy (IMRT). Radiother Oncol 2008;89:304-10. https://doi.org/10.1016/j.radonc.2008.07.026
  5. Walters BR, Ding GX, Kramer R, et al. Skeletal dosimetry in cone beam computed tomography. Med Phys 2009;36:2915-22. https://doi.org/10.1118/1.3147143
  6. 나종억, 이도근, 김진수, 백금문, 권경태. kV Cone Beam Computed Tomography(CBCT)를 이용한 전립선암 영상유도방사선치료 시 흡수선량 및 유효선량에 관한 고찰. 대한방사선치료학회지. 2009
  7. Timilsina B, Gesell TF: Independent evaluation of optically stimulated luminescence (OSL) ' dot' dosemeters for environmental monitoring. Radiat Prot Dosimetry 2011, 143:27-32. Epub 2010 Oct 14. https://doi.org/10.1093/rpd/ncq289
  8. E.G. Yukihara, S.W. McKeever. Optically stimulated luminescence (OSL) dosimetry in medicine. Phys Med Biol, 53 (2008), pp. R351-R379
  9. L.A. DeWerd, L.K. Wagner. Characteristics of radiation detectors for diagnostic radiology. Appl Radiat Isot, 50 (1999), pp. 125-136 https://doi.org/10.1016/S0969-8043(98)00044-X
  10. Pual A. Jursinic, et al.: Optically stimulated luminescence dosimeters for clinical dosimetric measurements. Med Phys 2007; 34:4594-4604 https://doi.org/10.1118/1.2804555
  11. G Ding , P Munro. Reduced CBCT Imaging Dose Due to the New X Ray Source in TrueBeam. Med. Phys. 38, 3372 (2011)